Navigation Links
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Date:6/26/2009

rtunistic infections, in patients with moderate or severe heart failure (NYHA Class III/IV), as well as in patients who are hypersensitive to SIMPONI or any of its excipients. Serious infections, including sepsis, pneumonia, tuberculosis, invasive fungal and other opportunistic infections have been observed with the use of TNF antagonists including SIMPONI. Some of these infections have been fatal. SIMPONI should not be given to patients with a clinically important, active infection. Caution should be exercised when considering the use of SIMPONI in patients with a chronic infection or a history of recurrent infection. Patients should be monitored for signs and symptoms of infection before, during and after treatment with SIMPONI. If a patient develops a serious infection or sepsis, SIMPONI therapy should be discontinued and appropriate antimicrobial therapy should be initiated. Patients should be advised of and avoid exposure to potential risk factors for infection as appropriate. For patients who have resided in or traveled to regions where invasive fungal infections such as histoplasmosis, coccidioidomycosis, or blastomycosis are endemic, the benefits and risks of SIMPONI treatment should be carefully considered before initiation of SIMPONI therapy. Patients must be evaluated for the risk of tuberculosis (TB), including latent tuberculosis, prior to initiation of SIMPONI. If active TB is diagnosed, SIMPONI must not be initiated. If latent TB is suspected then the benefit/risk balance should be considered for the following: treatment of latent tuberculosis infection should be initiated prior to therapy with SIMPONI. Antituberculosis therapy prior to initiating SIMPONI should also be considered in patients who have several or highly significant risk factors for tuberculosis infection and have a negative test for latent tuberculosis. Patients receiving SIMPONI should be monitored closely for signs and symptoms of active tuberculosis during and af
'/>"/>
SOURCE Schering-Plough Corporation; Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients
2. Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
3. Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
4. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
5. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
6. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
7. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
8. AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
9. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
10. Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma
11. Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... NORTHBROOK, Ill. , Sept. 16, 2014 /PRNewswire/ ... a new director of Business Communications & Advocacy, ... Vice President, Business Communications & Advocacy Margaret Long. In ... Astellas, commitment to urology to patient and advocacy ... brand teams on key strategic initiatives. Noland,s appointment ...
(Date:9/16/2014)... KANSAS CITY, Kan. , Sept. 16, 2014 ... ), a pet therapeutics company focused on licensing, ... animals, today announced that it is commencing an ... common stock.  All of the shares are being ... LLC and Barclays are acting as joint book-running ...
(Date:9/16/2014)... 2014 /PRNewswire-iReach/ -- Dan York has been ... of the RTD ® Advanced Wound Care Dressing, ... sales presence in the U.S. Under York,s leadership, GWM ... field sales representatives in new sales territories that will ... add up to 20 sales representatives in major metropolitan ...
Breaking Medicine Technology:Christy Noland to Lead Urology Advocacy and Communications for Astellas 2Aratana Therapeutics, Inc. Announces Proposed Public Offering 2GWM Products, LLC, announces U.S. market expansion. Dan York added as Director of Sales as part of nationwide growth initiative. 2
... Epiphany Biosciences announced,today, the initiation of a Phase ... and management of acute infectious,mononucleosis. Currently, there are ... condition or any other disease caused by,the Epstein-Barr ... spectrum of anti-viral activity,including inhibition of viral replication ...
... 6 Some 5,000 COPD patients will be ... (Alpha-1) in,a study marking a major cooperative effort ... Respiratory Care (AARC)., The principal investigator is ... Pulmonary Medicine, National Jewish Medical and Research Center,in ...
Cached Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3
(Date:9/17/2014)... (PRWEB) September 17, 2014 Kristen Yarker, MSc, ... the parents of children 9 months to 2 years old ... and furthermore, prevent picky eaters from developing by encouraging healthy ... Eating (9 months to 2 years): How to Transition From ... Child Is Getting the Nutrition They Need)” is a new ...
(Date:9/17/2014)... September 17, 2014 Angeldress.co.uk ... of graceful special occasion outfits for worldwide clients. According ... are thinking of opening the first flagship retail store. ... industry. Recently, the company has unveiled its new range ... , All its new products are offered at ...
(Date:9/17/2014)... Calif. (PRWEB) September 17, 2014 ... monthly interruptions, giving girls of all ages an ... wellness company founded by women, for women, announces ... Uninterrupted® (http://GirlU.com) to relieve the symptoms ... bloating and irritability. , As a lifelong ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 In a ... Diego, Dr. William Groff, an expert on the condition known ... Pearly penile papules , or PPP, is a condition ... although other men may be affected as well. The condition ... penis. , “While PPP is not a sexually transmitted ...
(Date:9/17/2014)... A raucous childhood in an Italian-Polish family and ... Nancy Chovancek’s laughter-filled new book, “Angry Birds and Beehive ... stories that prove the best way to deal with ... of empowerment and resilience, everyone can identify with Chovancek’s ... two books under her belt on the topic of ...
Breaking Medicine News(10 mins):Health News:Nutritionist Kristen Yarker Offers Parents a Fresh Approach to Prevent Picky Eaters in New Online Seminar 2Health News:Nutritionist Kristen Yarker Offers Parents a Fresh Approach to Prevent Picky Eaters in New Online Seminar 3Health News:Angeldress.co.uk Is Planning To Open Its First Retail Store And Offering Big Savings On Amazing Wedding Dresses 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 3Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 4Health News:New Video Depicts Best Treatment for PPP 2Health News:New Video Depicts Best Treatment for PPP 3
... genetic risk factors for rheumatoid arthritis (RA) have ... identified so far have been associated with autoantibody-positive ... but distinguishing this variant from autoantibody-negative RA, which ... A new study led by Diane van der ...
... tips from spinal experts helps professionals get back to ... professionals logging long hours at their desks, it,s not ... to Americans suffering from back pain.* This Administrative Professionals ... is helping administrative support professionals find relief. Simple ...
... Expertise to National OrganizationSPRINGFIELD, Va., April 7 ... organization dedicated to supporting those affected by the ... has selected Christine Brown to be its first ... management, program development, fundraising and advocacy relations to ...
... respondents say , , TUESDAY, April 7 (HealthDay News) -- Flavored ... and should carry warning labels, say many American adults who ... sweet drinks made to taste like cola or soda pop ... 8 percent alcohol content, which is a little bit more ...
... LAKE CITY University of Utah researchers have found ... predicting treatment outcomes and measuring disease progression for patients ... disorder that affects more than 3.5 million Americans and ... study on a novel application of this technology for ...
... expectation may be factors in helping older adults ... with the Birmingham Veterans Administration Medical Center and ... published in March in the Annals of ... for surgery returned to normal baseline function more ...
Cached Medicine News:Health News:Genetic risk factors play role in autoantibody-negative rheumatoid arthritis 2Health News:Laser Spine Institute Helps Professionals Take Back Their Lives from Debilitating Back Pain 2Health News:Laser Spine Institute Helps Professionals Take Back Their Lives from Debilitating Back Pain 3Health News:The National PKU Alliance Expands Leadership and Names Christine Brown as Executive Director 2Health News:The National PKU Alliance Expands Leadership and Names Christine Brown as Executive Director 3Health News:Parents Worry That 'Alcopops' Encourage Teen Drinking 2Health News:U study shows MRI-based method holds promise for predicting treatment outcomes in patients with AF 2Health News:VA/UAB study looks at functional decline in older patients after hospitalization 2Health News:VA/UAB study looks at functional decline in older patients after hospitalization 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: